Health Technology
Italian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Safilo Group S.p.A. dominates trading volume, whereas Moderna, Inc. logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 4LLYEli Lilly and Company | 1.19 T EUR | 1,222.0 EUR | −2.86% | 0 | 0.00 | 45.48 | 26.87 EUR | +55.94% | 0.47% | Strong buy |
 4JNJJohnson & Johnson | 592.45 B EUR | 244.95 EUR | −0.81% | 0 | 0.00 | 42.09 | 5.82 EUR | −34.10% | 1.91% | Buy |
 4ABBVAbbVie, Inc. | 464.16 B EUR | 259.6 EUR | −1.18% | 0 | — | 50.61 | 5.13 EUR | +354.14% | 2.35% | Buy |
 4MRKXMerck & Co., Inc. | 330.4 B EUR | 131.56 EUR | −1.82% | 100 | — | 152.20 | 0.86 EUR | −86.58% | 2.26% | Buy |
 4TMOThermo Fisher Scientific Inc. | 233.03 B EUR | 618.0 EUR | −0.32% | 0 | 0.00 | 36.94 | 16.73 EUR | +13.44% | 0.26% | Buy |
 4AMGNAmgen Inc. | 230.4 B EUR | 413.60 EUR | −0.96% | 0 | 0.00 | 27.18 | 15.22 EUR | +38.07% | 2.08% | Neutral |
 4GILDGilead Sciences, Inc. | 192.75 B EUR | 150.38 EUR | −2.01% | 0 | — | — | −2.78 EUR | −150.52% | 1.86% | Buy |
 4PFEPfizer Inc. | 156.31 B EUR | 26.300 EUR | −3.31% | 0 | 0.00 | 42.61 | 0.62 EUR | −57.78% | 5.59% | Neutral |
 4ISRGIntuitive Surgical, Inc. | 148.84 B EUR | 410.45 EUR | −2.20% | 0 | 0.00 | 56.26 | 7.30 EUR | +13.32% | 0.00% | Buy |
 4DHRDanaher Corporation | 147.21 B EUR | 204.1 EUR | −0.63% | 0 | 0.00 | 37.86 | 5.39 EUR | +30.20% | 0.65% | Buy |
 4VRTXVertex Pharmaceuticals Incorporated | 123.98 B EUR | 490.00 EUR | +1.58% | 0 | — | 35.71 | 13.72 EUR | +13.49% | 0.00% | Buy |
 4MDTMedtronic Plc | 119.58 B EUR | 91.78 EUR | −1.25% | 0 | — | 26.03 | 3.53 EUR | +11.12% | 2.72% | Buy |
 4BMYBristol-Myers Squibb Company | 116.86 B EUR | 56.01 EUR | −1.70% | 0 | — | 14.06 | 3.98 EUR | +57.85% | 3.93% | Buy |
 4SYKStryker Corporation | 115.16 B EUR | 292.6 EUR | −2.56% | 0 | 0.00 | 35.31 | 8.29 EUR | +27.68% | 1.04% | Buy |
 4SANSanofi SA | 100.88 B EUR | 83.51 EUR | −1.42% | 0 | 0.00 | 25.08 | 3.33 EUR | −35.60% | 4.90% | Buy |
 4MRNAModerna, Inc. | 91.88 B EUR | 236.10 EUR | +7.42% | 210 | 6.05 | — | −6.99 EUR | −9.55% | 0.00% | Neutral |
 4ELEssilorLuxottica SA | 87.56 B EUR | 194.35 EUR | +1.46% | 40 | 0.44 | 36.32 | 5.35 EUR | +3.83% | 2.12% | Buy |
 4REGNRegeneron Pharmaceuticals, Inc. | 85.73 B EUR | 807.8 EUR | −1.54% | 0 | — | 20.20 | 39.99 EUR | +12.33% | 0.40% | Buy |
 4MRKMerck KGaA | 65.41 B EUR | 148.70 EUR | −1.00% | 0 | — | 27.28 | 5.45 EUR | −17.22% | 1.46% | Buy |
 4BSXBoston Scientific Corporation | 59.15 B EUR | 38.810 EUR | −2.97% | 0 | 0.00 | 18.61 | 2.09 EUR | +30.86% | 0.00% | Buy |
 4UCBUCB S.A. | 53.69 B EUR | 291.1 EUR | 0.00% | 0 | 0.00 | 25.75 | 11.31 EUR | +64.98% | 0.36% | Buy |
 4BAYNBayer AG | 53.29 B EUR | 55.22 EUR | −1.81% | 30 | 0.08 | — | −1.77 EUR | +49.15% | 0.20% | Buy |
 4EWEdwards Lifesciences Corporation | 51.01 B EUR | 90.26 EUR | +0.42% | 0 | — | 61.17 | 1.48 EUR | +18.67% | 0.00% | Buy |
 4BDXBecton, Dickinson and Company | 50.75 B EUR | 191.65 EUR | +2.35% | 0 | — | 66.02 | 2.90 EUR | −38.51% | 2.01% | Buy |
 4SHLSiemens Healthineers AG | 50.04 B EUR | 44.56 EUR | −1.33% | 0 | — | 22.57 | 1.97 EUR | +2.35% | 2.23% | Buy |
 4AAgilent Technologies, Inc. | 44.49 B EUR | 156.05 EUR | +0.35% | 0 | 0.00 | 35.40 | 4.41 EUR | +18.01% | 0.58% | Buy |
 4BIIBBiogen Inc. | 33.5 B EUR | 222.25 EUR | −0.63% | 0 | — | 107.78 | 2.06 EUR | −77.93% | 0.00% | Buy |
 4ZTSZoetis, Inc. Class A | 32.83 B EUR | 71.56 EUR | −4.18% | 0 | — | 13.44 | 5.32 EUR | +7.88% | 2.38% | Neutral |
 4INCYIncyte Corporation | 22.3 B EUR | 106.35 EUR | −1.16% | 0 | — | 64.11 | 1.66 EUR | −67.34% | 0.00% | Buy |
 4DIMSartorius Stedim Biotech SA | 21.76 B EUR | 225.0 EUR | −0.35% | 0 | 0.00 | 67.59 | 3.33 EUR | +22.74% | 0.31% | Strong buy |
 4VTRSViatris, Inc. | 19.66 B EUR | 17.322 EUR | +1.33% | 0 | 0.00 | — | −0.31 EUR | +87.33% | 2.50% | Buy |
| 4SRT3Sartorius AG Pref | 17.83 B EUR | 289.9 EUR | +0.03% | 0 | — | 91.66 | 3.16 EUR | +63.32% | 0.26% | Buy |
| 4SRTSartorius AG | 17.83 B EUR | 227.0 EUR | 0.00% | 0 | 0.00 | 71.77 | 3.16 EUR | +63.32% | 0.32% | Buy |
 4ORNBVOrion Oyj Class B | 14.23 B EUR | 101.60 EUR | +0.40% | 0 | — | 21.71 | 4.68 EUR | +110.09% | 1.77% | Neutral |
 4BAXBaxter International Inc. | 12.21 B EUR | 22.87 EUR | +0.04% | 0 | — | — | −1.22 EUR | −174.16% | 0.15% | Neutral |
 RECRecordati S.p.A. | 10.96 B EUR | 53.25 EUR | +0.38% | 283.33 K | 0.65 | 22.37 | 2.38 EUR | +22.24% | 2.52% | Neutral |
 4BMRNBioMarin Pharmaceutical Inc. | 9.86 B EUR | 50.06 EUR | −1.61% | 0 | — | — | −0.09 EUR | −104.02% | 0.00% | Buy |
 4GRFGrifols, S.A. Class A | 6.67 B EUR | 11.185 EUR | −1.15% | 0 | — | 16.83 | 0.66 EUR | +51.93% | 1.68% | Buy |
 DIADiaSorin S.p.A. | 4.43 B EUR | 82.64 EUR | +2.48% | 209.9 K | 1.86 | 31.26 | 2.64 EUR | −23.38% | 1.58% | Neutral |
 4OGNOrganon & Co. | 3.23 B EUR | 12.258 EUR | −0.49% | 0 | — | 18.06 | 0.68 EUR | −58.61% | 0.58% | Neutral |
 4AFXCarl Zeiss Meditec AG | 3.2 B EUR | 35.12 EUR | −2.44% | 0 | — | 32.41 | 1.08 EUR | −38.81% | 1.54% | Sell |
 4LKFTLakefront Biotherapeutics | 1.96 B EUR | 29.76 EUR | −2.04% | 0 | — | 3.29 | 9.05 EUR | — | 0.00% | Buy |
 4XRAYDENTSPLY SIRONA, Inc. | 1.89 B EUR | 8.572 EUR | −5.66% | 0 | — | — | −2.40 EUR | +40.51% | 3.00% | Neutral |
 ELNEl.En. S.p.A. | 1.34 B EUR | 15.96 EUR | −0.56% | 26.22 K | 0.61 | 25.33 | 0.63 EUR | +21.15% | 1.50% | Strong buy |
 4EUZEckert & Ziegler SE | 876.04 M EUR | 13.85 EUR | −0.93% | 0 | — | 17.51 | 0.79 EUR | +35.27% | 1.57% | Strong buy |
 SFLSafilo Group S.p.A. | 798.22 M EUR | 2.040 EUR | −1.64% | 595.05 K | 1.16 | 17.07 | 0.12 EUR | +6.60% | 0.00% | Buy |
 PHNPharmaNutra S.p.A. | 701.87 M EUR | 74.4 EUR | +1.92% | 12.51 K | 1.46 | 34.36 | 2.17 EUR | +23.06% | 1.66% | Strong buy |
 PHILPhilogen SpA | 611.18 M EUR | 21.15 EUR | +2.67% | 3.48 K | 0.37 | 3.79 | 5.58 EUR | +390.98% | 3.35% | Buy |
 4VLAValneva SE | 481.73 M EUR | 2.504 EUR | −2.34% | 0 | — | — | −0.90 EUR | −117.39% | 0.00% | Strong buy |
 FFFine Foods & Pharmaceuticals N.T.M. SpA | 153.99 M EUR | 6.16 EUR | +0.98% | 22.12 K | 0.76 | — | −0.05 EUR | −110.39% | 2.54% | Buy |
 4IPHInnate Pharma SA Class A | 140.07 M EUR | 1.272 EUR | +1.44% | 0 | — | — | −0.51 EUR | +7.91% | 0.00% | Strong buy |
 ENVEnervit S.p.A. | 82.06 M EUR | 4.48 EUR | −0.88% | 725 | 0.21 | 19.05 | 0.24 EUR | −6.00% | 4.66% | No rating |
 SVSSvas Biosana S.p.A. | 42.74 M EUR | 8.00 EUR | 0.00% | 390 | 0.66 | 6.64 | 1.21 EUR | +0.12% | 2.50% | Strong buy |
 IMDI.M.D. International Medical Devices S.P.A. | 21.48 M EUR | 1.24 EUR | 0.00% | 0 | 0.00 | 17.10 | 0.07 EUR | −6.33% | 5.65% | No rating |
 ARBSArterra Bioscience SpA | 20.04 M EUR | 3.02 EUR | 0.00% | 1.5 K | 0.49 | 12.09 | 0.25 EUR | −12.69% | 4.98% | No rating |
 HLXHelyx Industries S.p.A. | 15.76 M EUR | 0.620 EUR | +3.68% | 23 K | 0.38 | — | −0.13 EUR | +40.07% | 0.00% | Strong buy |
 OTOOtofarma S.P.A. | 12.61 M EUR | 2.16 EUR | 0.00% | 0 | 0.00 | — | −0.16 EUR | — | 0.00% | Neutral |
 IVNIvision Tech S.P.A. | 10.78 M EUR | 1.295 EUR | +5.71% | 24 K | 1.60 | 239.81 | 0.01 EUR | +237.50% | 0.00% | Strong buy |
 ERFOLaboratorio Farmaceutico Erfo SpA | 9.23 M EUR | 1.080 EUR | −0.46% | 3 K | 0.46 | 23.28 | 0.05 EUR | +2.43% | 0.00% | Strong buy |
 PREPredict S.P.A. Class B | 7.36 M EUR | 0.940 EUR | −2.08% | 3 K | 0.25 | 11.38 | 0.08 EUR | +177.18% | 0.00% | Strong buy |